Trial Profile
The Effect of Ferric Citrate on Inflammation and Lipid Levels in Patients on Hemodialysis
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 24 Apr 2023
Price :
$35
*
At a glance
- Drugs Ferric citrate (Primary)
- Indications Hyperphosphataemia
- Focus Biomarker; Pharmacodynamics
- 30 Mar 2023 Status changed from recruiting to discontinued.
- 04 Jan 2018 New trial record